AstraZeneca reported positive results from clinical trial programs for Brilinta and Farxiga, causing stock to jump 3.4 percent.

In a late-stage study, Genentech’s flu drug Xofluza showed significant efficacy as a preventative treatment.

AbbVie Inc. will cease to develop the experimental drug Rova-T after failing to show survival benefit in a late-stage trial for a type of lung cancer.

AstraZeneca’s experimental drug to treat moderate-to-severe lupus met the main goal in a late-stage trial. During 2018, anifrolumab failed to meet the primary target in the final stage of another study.

People who start fasting every other day may lose more weight than they would if they stuck to their usual eating habits, a small study suggests.

Researchers may have found a solution to treating a bone marrow cancer proven to be resistant to several standard therapies.

GlaxoSmithKline said an experimental multiple myeloma treatment showed a meaningful response in patients that have run out of three previous treatment options.

San Francisco-based Mission Bio Inc. launched an addition to the company’s Tapestri Platform that provides it the ability to track the full scope genomics of cancer in terms of single-cell capabilities.

GlaxoSmithKline’s experimental HIV injection is as effective when given every other month as monthly, according to a study

Retrophin Inc. said on Thursday the company’s treatment for a rare neurological disorder failed to meet the main goal of improving patient’s ability to conduct daily activities in a late-stage study.